Projects
Research
What risk does underlying trimethoprim resistance pose for the development of cotrimoxazole-resistant skin infectionsInvestigating what risk does underlying trimethoprim resistance pose for the development of cotrimoxazole-resistant skin infections.
Research
Tonsil organ model to evaluate carriage, disease mechanisms and therapeutic interventions for treatment and prevention of GAS infectionsTonsil organ model to evaluate carriage, disease mechanisms and therapeutic interventions for treatment and prevention of Group A Streptococcal infections.
Research
The NZ BPG Pharmacokinetics StudyJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is
Research
The END RHD CRE: Developing an end game for rheumatic heart disease in AustraliaJonathan Glenn Katharine Rosemary Tom Carapetis AM Pearson Noonan Wyber Snelling AM MBBS FRACP FAFPHM PhD FAHMS BA (Education) PhD Candidate MBBS (Hons) MSc MBChB MPH FRACGP PhD BMBS DTMH GDipClinEpid PhD FRACP Executive Director; Co-Head, Strep A
Research
Australian Strep A Vaccine Initiative (ASAVI)The Australian Strep A Vaccine Initiative (ASAVI) is an Australian-led global initiative with the goal of reducing the disease burden caused by Group A Streptococcus (Strep A) infection through effective vaccination.